Horizon Discovery Group Limited, commonly referred to as Horizon, is a leading biotechnology company headquartered in Great Britain. Founded in 2007, Horizon has established itself as a key player in the life sciences industry, specialising in gene editing and gene modulation technologies. With a strong operational presence across Europe and North America, the company focuses on providing innovative solutions for drug discovery and development. Horizon’s core offerings include a range of custom cell lines, CRISPR gene editing services, and gene modulation tools, which are distinguished by their precision and reliability. The company has achieved significant milestones, including partnerships with major pharmaceutical firms, enhancing its market position as a trusted provider of genomic solutions. With a commitment to advancing research and therapeutic development, Horizon Discovery continues to drive innovation in the biotechnology sector.
We don't have data for Horizon Discovery Group Limited, but we can show you information about their parent organization instead.
View parent company